Skip Navigation
Skip to contents

Intest Res : Intestinal Research

IMPACT FACTOR

Author index

Page Path
HOME > Browse articles > Author index
Search
Chien-Chih Tung 5 Articles
IBD
Association of young age and male sex with primary sclerosing cholangitis in Taiwanese patients with inflammatory bowel disease
Meng-Tzu Weng, I-Lun Shih, Chien-Chih Tung, Yew-Loong Leong, Ming-Jium Shieh, Cheng-Yi Wang, Jau-Min Wong, Yen-Hsuan Ni, Shu-Chen Wei
Intest Res 2022;20(2):224-230.   Published online February 8, 2022
DOI: https://doi.org/10.5217/ir.2021.00042
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Background/Aims
Primary sclerosing cholangitis (PSC) is associated with inflammatory bowel disease (IBD). We aimed to evaluate the prevalence, clinical manifestation, and outcomes of PSC in Taiwanese patients with IBD. Methods: This retrospective study enrolled patients with IBD admitted from January 1, 1996, to December 31, 2018, to National Taiwan University Hospital. A case-matched analysis was performed comparing patients with IBD with and without PSC according to age, sex, and time of admission, with ratios of 1:4 and 1:2 in the adult and pediatric groups, respectively.
Results
In total, 763 patients with IBD were enrolled, 12 of whom were also diagnosed with PSC (1.57%). All these patients had ulcerative colitis (UC). A greater incidence of IBD with PSC was observed in younger patients than in older patients. Male sex was a risk factor for PSC in pediatric patients with IBD (P=0.015); 75% of these patients were diagnosed with PSC along with or after the diagnosis of UC. There was no significant difference in colitis extent and severity between the groups; however, a higher proportion of rectal sparing was observed in patients with PSC (P=0.001). There was no significant difference in cancer development between the groups (P=0.679). Conclusions: A 1.57% prevalence of PSC was observed in Taiwanese patients with IBD. The majority of patients with IBD and PSC were men and were diagnosed at a younger age. Hence, routine evaluation of biliary enzymes and liver imaging is recommended in young male patients with IBD.

Citations

Citations to this article as recorded by  
  • Hepatic Steatosis but Not Fibrosis Is Independently Associated with Poor Outcomes in Patients with Inflammatory Bowel Disease
    Hye Kyung Hyun, Hye Won Lee, Jihye Park, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jae Seung Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim, Jae Hee Cheon
    Gut and Liver.2024; 18(2): 294.     CrossRef
  • Safety of Biologics and Small Molecules for Inflammatory Bowel Diseases in Organ Transplant Recipients
    Ga Hee Kim, Minjun Kim, Kyuwon Kim, Jung-Bin Park, Ji Eun Baek, June Hwa Bae, Seung Wook Hong, Sung Wook Hwang, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Sang Hyoung Park
    Yonsei Medical Journal.2024; 65(5): 276.     CrossRef
  • Incidence and adverse clinical events of primary sclerosing cholangitis with ulcerative colitis
    In Sub Han, Dong Hoon Baek, Seung Min Hong, Bong Eun Lee, Moon Won Lee, Gwang Ha Kim, Geun Am Song
    International Journal of Colorectal Disease.2023;[Epub]     CrossRef
  • Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut–liver axis
    You Sun Kim, Edward H. Hurley, Yoojeong Park, Sungjin Ko
    Experimental & Molecular Medicine.2023; 55(7): 1380.     CrossRef
  • Treatment of primary sclerosing cholangitis combined with inflammatory bowel disease
    You Sun Kim, Edward H. Hurley, Yoojeong Park, Sungjin Ko
    Intestinal Research.2023; 21(4): 420.     CrossRef
  • Regional variations in the prevalence of primary sclerosing cholangitis associated with inflammatory bowel disease
    Kwang Woo Kim, Hyoun Woo Kang
    Intestinal Research.2023; 21(4): 413.     CrossRef
  • Is primary sclerosing cholangitis with inflammatory bowel disease different between patients in the East and West?
    Yong Eun Park
    Intestinal Research.2022; 20(2): 157.     CrossRef
  • 4,791 View
  • 268 Download
  • 8 Web of Science
  • 7 Crossref
Close layer
IBD
Epidemiological trend in inflammatory bowel disease in Taiwan from 2001 to 2015: a nationwide populationbased study
Hsu-Heng Yen, Meng-Tzu Weng, Chien-Chih Tung, Yu-Ting Wang, Yuan Ting Chang, Chin-Hao Chang, Ming-Jium Shieh, Jau-Min Wong, Shu-Chen Wei
Intest Res 2019;17(1):54-62.   Published online November 20, 2018
DOI: https://doi.org/10.5217/ir.2018.00096
AbstractAbstract PDFPubReaderePub
Background/Aims
Incidences of inflammatory bowel diseases (IBDs), ulcerative colitis (UC), and Crohn’s disease (CD), have been increasing in Asia. In this study, we report the relevant clinical characteristics and determined the epidemiological trend of IBD in Taiwan from 2001 to 2015.
Methods
A retrospective study was conducted to analyze data recorded from January 2001 through December 2015 in the registered database compiled by the National Health Insurance and provided by the Ministry of Health and Welfare, Taiwan.
Results
A total of 3,806 patients with catastrophic IBD illness were registered from 2001 to 2015 in Taiwan (CD, 919; UC, 2,887). The crude incidence of CD increased from 0.17/100,000 in 2001 to 0.47/100,000 in 2015, whereas that of UC increased from 0.54/100,000 in 2001 to 0.95/100,000 in 2015. The prevalence of CD increased from 0.6/100,000 in 2001 to 3.9/100,000 in 2015, whereas that of UC increased from 2.1/100,000 in 2001 to 12.8/100,000 in 2015. The male-to-female ratio in the study sample was 2.19 for CD and 1.62 for UC. The median age of those registered with CD was lower than that of those registered for UC: 38.86 and 44.86 years, respectively. A significantly greater increase in CD incidence rate was identified among 20 to 39-year-old compared with other age groups.
Conclusions
Using Taiwan’s nationwide insurance database, we determined that the number of patients with CD increased more rapidly during the study period than the number of patients with UC, especially among age 20 to 39-year-old, resulting in a decreased UC-to-CD ratio.

Citations

Citations to this article as recorded by  
  • Association between nonalcoholic fatty liver disease and incidence of inflammatory bowel disease: a nationwide population‑based cohort study
    Ying-Hsiang Wang, Chi-Hsiang Chung, Tien-Yu Huang, Chao-Feng Chang, Chi-Wei Yang, Wu-Chien Chien, Yi-Chiao Cheng
    Intestinal Research.2025; 23(1): 76.     CrossRef
  • Global Epidemiology and Geographic Variations of Pediatric-Onset Inflammatory Bowel Disease: A Comprehensive Analysis of the Global Burden of Disease Study 1990 to 2019
    Yichen Wang, Chun-Wei Pan, Yuting Huang, Xin Zheng, Si Li, Mingyue He, Jana G Hashash, Francis A Farraye, Adam C Ehrlich
    Inflammatory Bowel Diseases.2025; 31(2): 376.     CrossRef
  • Clinical Characteristics, Management, and Outcomes of Colitis-Associated Colorectal Cancer and the Comparison With Sporadic Colorectal Cancer in Taiwan
    Hsin-Yun Wu, Meng-Tzu Weng, Jen-Wei Chou, Hsu-Heng Yen, Chun-Chi Lin, Feng-Fan Chiang, Chen-Shuan Chung, Wei-Chen Lin, Chen-Wang Chang, Puo-Hsien Le, Chia-Jung Kuo, Ching-Pin Lin, Wen-Hung Hsu, Chiao-Hsiung Chuang, Tzung-Jiun Tsai, I-Che Feng, Shu-Chen We
    Clinical and Translational Gastroenterology.2025; 16(2): e00798.     CrossRef
  • Short-term and long-term outcomes of acute severe ulcerative colitis in Taiwan: a multicenter study with pre- and post-biologics comparison
    Wei-Chen Lin, Chun-Chi Lin, Wen-Hung Hsu, Feng-Fan Chiang, Chen-Wang Chang, Tzu-Chi Hsu, Deng-Chyang Wu, Horng-Yuan Wang, Jau-Min Wong, Shu-Chen Wei
    Intestinal Research.2025;[Epub]     CrossRef
  • Endoscopic Techniques for Colorectal Neoplasia Surveillance in Inflammatory Bowel Disease: A Systematic Review and Network Meta‐Analysis
    Chih‐Wen Huang, Hsu‐Heng Yen, Yang‐Yuan Chen
    United European Gastroenterology Journal.2025;[Epub]     CrossRef
  • Crohn’s disease but not ulcerative colitis elevated risk of end-stage renal disease and mortality: A Taiwan retrospective cohort study
    Ming-Che Chuang, Tzu-Ju Hsu, Fuu-Jen Tsai, Jye-Lin Hsu, Tsung-Yu Tsai
    Medicine.2025; 104(14): e42026.     CrossRef
  • Leucine-rich alpha-2 glycoprotein is useful in predicting clinical relapse in patients with Crohn’s disease during biological remission
    Naohiro Nakamura, Yusuke Honzawa, Yuka Ito, Yasuki Sano, Naoto Yagi, Sanshiro Kobayashi, Mamiko Aoi, Takashi Tomiyama, Tomomitsu Tahara, Norimasa Fukata, Toshiro Fukui, Makoto Naganuma
    Intestinal Research.2025; 23(2): 170.     CrossRef
  • Serological Assessment of Hepatitis in Patients with Inflammatory Bowel Disease in Taiwan: A Retrospective Cohort Analysis
    Yueh-An Lee, Hsu-Heng Yen, Yang-Yuan Chen
    Life.2025; 15(6): 893.     CrossRef
  • Attitudes to medication and effects of IBD nursing service among patients with inflammatory bowel disease in Taiwan
    Chen‐Ta Yang, Tsui‐Chun Hsu, Yang‐Yuan Chen, Siou‐Ping Huang, Hsu‐Heng Yen
    Advances in Digestive Medicine.2024; 11(3): 162.     CrossRef
  • 27-Hydroxycholesterol activates the GSK-3β/β-catenin signaling pathway resulting in intestinal fibrosis by inducing oxidative stress: effect of dietary interventions
    Wei Xiao, Chunyan Hu, Yifan Ni, Jie Wang, Kailin Jiao, Ming Zhou, Zhong Li
    Inflammation Research.2024; 73(2): 289.     CrossRef
  • Unraveling the blood microbiome: novel insights into inflammasome responses in Crohn’s disease
    Duygu Kirkik, Sevgi Kalkanli Tas, Alpaslan Tanoglu
    European Journal of Gastroenterology & Hepatology.2024; 36(8): 975.     CrossRef
  • Magnifying Endoscopy With Narrow Band Imaging for Graft Failure and Disease Recurrence in Patients With Crohn Disease After Intestinal Transplantation: 2 Case Reports
    Chen-Huan Yu, Yun Chen, Chien-Chen Tsai, Tzong-Hsi Lee, Ya-Hui Tsai, Chen-Shuan Chung
    Transplantation Proceedings.2024; 56(2): 422.     CrossRef
  • Risk factors of mortality following hospital admission for Crohn's disease: A cohort study at a tertiary referral center in Taiwan
    Po‐Han Huang, Wey‐Ran Lin, Puo‐Hsien Le, Cheng‐Yu Lin, Chun‐Wei Chen, Ren‐Chin Wu, Jun‐Te Hsu, Wen‐Sy Tsai, Ming‐Wei Lai, Sen‐Yung Hsieh, Ming‐Yao Su, Cheng‐Tang Chiu, Chia‐Jung Kuo
    Advances in Digestive Medicine.2024; 11(2): 81.     CrossRef
  • Exacerbated gastrointestinal symptoms and long COVID in IBD patients with SARS-CoV-2 infection: A multi-center study from taiwan
    Tsung-Yu Tsai, Jia-Feng Wu, Meng-Tzu Weng, Chiao-Hsiung Chuang, Tien-Yu Huang, Wei-Chen Tai, Chi-Ming Tai, Chen-Shuan Chung, Chih-Cheng Chen, Ching-Pin Lin, Yuan-Yao Tsai, Shu-Chen Wei
    Journal of the Formosan Medical Association.2024; 123(8): 866.     CrossRef
  • Temporal Trends of Inflammatory Bowel Diseases in Taiwan from 2016 to 2020: A Population-Based Study
    Chia-Jung Kuo, Cheng-Yu Lin, Puo-Hsien Le, Yao-Wei Kuo, Chen-Ming Hsu, Ming-Wei Lai, Wey-Ran Lin, Ming-Ling Chang, Ming-Yao Su, Cheng-Tang Chiu, Chee-Jen Chang
    Digestive Diseases and Sciences.2024; 69(9): 3172.     CrossRef
  • High prevalence of vitamin D deficiency in Taiwanese patients with inflammatory bowel disease
    Chen-Ta Yang, Hsu-Heng Yen, Pei-Yuan Su, Yang-Yuan Chen, Siou-Ping Huang
    Scientific Reports.2024;[Epub]     CrossRef
  • Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease updated in 2023
    Hsu-Heng Yen, Jia-Feng Wu, Horng-Yuan Wang, Ting-An Chang, Chung-Hsin Chang, Chen-Wang Chang, Te-Hsin Chao, Jen-Wei Chou, Yenn-Hwei Chou, Chiao-Hsiung Chuang, Wen-Hung Hsu, Tzu-Chi Hsu, Tien-Yu Huang, Tsung-I Hung, Puo-Hsien Le, Chun-Che Lin, Chun-Chi Lin
    Intestinal Research.2024; 22(3): 213.     CrossRef
  • Management of Crohn’s disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease updated in 2023
    Jia-Feng Wu, Hsu-Heng Yen, Horng-Yuan Wang, Ting-An Chang, Chung-Hsin Chang, Chen-Wang Chang, Te-Hsin Chao, Jen-Wei Chou, Yenn-Hwei Chou, Chiao-Hsiung Chuang, Wen-Hung Hsu, Tzu-Chi Hsu, Tien-Yu Huang, Tsung-I Hung, Puo-Hsien Le, Chun-Che Lin, Chun-Chi Lin
    Intestinal Research.2024; 22(3): 250.     CrossRef
  • Persistence of newly prescribed 5-aminosalicylic acid in patients with ulcerative colitis: A nationwide comprehensive database study
    Tatsuya Noda, Kotaro Kuwaki, Munehito Machida, Yasuyuki Okumura, Yuichi Nishioka, Tomoya Myojin, Tomoaki Imamura, Barry Kweh
    PLOS ONE.2024; 19(12): e0316181.     CrossRef
  • Real‐world experience of adalimumab therapy for patients with ulcerative colitis: A single tertiary medical center experience in Central Taiwan
    Hsu‐Heng Yen, Yu‐Chun Hsu, Chu‐Hsuan Kuo, Tsui‐Chun Hsu, Yang‐Yuan Chen
    Advances in Digestive Medicine.2023; 10(1): 28.     CrossRef
  • Real-World Evidence of Effectiveness and Safety of Vedolizumab for Inflammatory Bowel Disease in Taiwan: A Prospective Nationwide Registry (VIOLET) Study
    Wei-Chen Lin, Wei-Chen Tai, Chung-Hsin Chang, Chia-Hung Tu, I-Che Feng, Ming-Jium Shieh, Chen-Shuan Chung, Hsu-Heng Yen, Jen-Wei Chou, Jau-Min Wong, Yu-Hwa Liu, Tien-Yu Huang, Chiao-Hsiung Chuang, Tzung-Jiun Tsai, Feng-Fan Chiang, Chien-Yu Lu, Wen-Hung Hs
    Inflammatory Bowel Diseases.2023; 29(11): 1730.     CrossRef
  • Seronegative spondyloarthropathy-associated inflammatory bowel disease
    Chrong-Reen Wang, Hung-Wen Tsai
    World Journal of Gastroenterology.2023; 29(3): 450.     CrossRef
  • Synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome associated with inflammatory bowel disease: Report of four patients
    Mingwei Ma, Yuchen Liu, Shengyan Liu, Chen Li
    International Journal of Rheumatic Diseases.2023; 26(5): 996.     CrossRef
  • Bronchoesophageal fistula in a patient with Crohn’s disease receiving anti-tumor necrosis factor therapy
    Kyunghwan Oh, Kee Don Choi, Hyeong Ryul Kim, Tae Sun Shim, Byong Duk Ye, Suk-Kyun Yang, Sang Hyoung Park
    Clinical Endoscopy.2023; 56(2): 239.     CrossRef
  • Serum amyloid protein A in inflammatory bowel disease: from bench to bedside
    Rirong Chen, Qia Chen, Jieqi Zheng, Zhirong Zeng, Minhu Chen, Li Li, Shenghong Zhang
    Cell Death Discovery.2023;[Epub]     CrossRef
  • Treatment of inflammatory bowel disease–Asian perspectives: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting
    Eun Mi Song, Soo-Young Na, Sung Noh Hong, Siew Chien Ng, Tadakazu Hisamatsu, Byong Duk Ye
    Intestinal Research.2023; 21(3): 339.     CrossRef
  • Diagnosis of inflammatory bowel disease–Asian perspectives: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting
    Han Hee Lee, Jae Jun Park, Bo-In Lee, Ida Hilmi, Jose Sollano, Zhi Hua Ran
    Intestinal Research.2023; 21(3): 328.     CrossRef
  • Risk of Attempted Suicide Among Patients With IBD: A Nationwide Longitudinal Follow-up Study
    Yen-Po Wang, Bing Zhang, Hohui E. Wang, Ya-Mei Bai, Shih-Jen Tsai, Tzeng-Ji Chen, Mu-Hong Chen
    Diseases of the Colon & Rectum.2023; 66(9): e938.     CrossRef
  • Suboptimal Outcomes and Retreatment Rate of Patients With Crohn's Disease After Forced Discontinuation of Biologics: A Nationwide Population‐Based Study
    Nai‐Yu Chen, Chiao‐Hsiung Chuang, Yu‐Ching Chang, Yea‐Huei Kao Yang, Peng‐Hsu Chen, Ching‐Lan Cheng
    Clinical Pharmacology & Therapeutics.2023; 114(4): 914.     CrossRef
  • Metabolic Dysfunction-Associated Fatty Liver Disease in Taiwanese Patients with Inflammatory Bowel Disease: A Study in Patients with Clinical Remission
    Shun-Wen Hsiao, Ting-Chun Chen, Pei-Yuan Su, Chen-Ta Yang, Siou-Ping Huang, Yang-Yuan Chen, Hsu-Heng Yen
    Diagnostics.2023; 13(20): 3268.     CrossRef
  • The Prevalence and Risk Factors of Clostridioides difficile Infection in Inflammatory Bowel Disease: 10-Year South Korean Experience Based on the National Database
    Eun Mi Song, Arum Choi, Sukil Kim, Sung Hoon Jung
    Journal of Korean Medical Science.2023;[Epub]     CrossRef
  • Increasing Prevalence and Stable Incidence Rates of Inflammatory Bowel Disease Among First Nations: Population-Based Evidence From a Western Canadian Province
    Juan Nicolás Peña-Sánchez, Jessica Amankwah Osei, Jose Diego Marques Santos, Derek Jennings, Mustafa Andkhoie, Colten Brass, Germain Bukassa-Kazadi, Xinya Lu, Michelle Johnson-Jennings, Linda Porter, Rob Porter, Carol-Lynne Quintin, Rhonda Sanderson, Ulri
    Inflammatory Bowel Diseases.2022; 28(4): 514.     CrossRef
  • New‐onset Crohn's disease after interleukin‐17A inhibitor therapy with secukinumab: A report of an unusual case
    Tung‐Lung Wu, Hui‐Ting Hsu, Hsu‐Heng Yen, Yang‐Yuan Chen
    Advances in Digestive Medicine.2022; 9(3): 200.     CrossRef
  • Impact of short-chain fatty acid supplementation on gut inflammation and microbiota composition in a murine colitis model
    Jae Gon Lee, Jiyoung Lee, A-reum Lee, Su Vin Jo, Chan Hyuk Park, Dong Soo Han, Chang Soo Eun
    The Journal of Nutritional Biochemistry.2022; 101: 108926.     CrossRef
  • The effectiveness and safety of vedolizumab induction for moderate to severe ulcerative colitis for Asia patient: A real practice observational study
    Chia-Jung Kuo, Puo-Hsien Le, Wei-Chen Tai, Keng-Liang Wu, Hsu-Heng Yen, Chih-Wei Yen, Shui-Yi Tung, Chen-Shuan Chung, Ming-Yao Su, Cheng-Tang Chiu
    Journal of the Formosan Medical Association.2022; 121(9): 1689.     CrossRef
  • Infliximab versus Adalimumab: Can We Choose the Right One for the Right Patients with Ulcerative Colitis?
    Sang Hyoung Park, Byong Duk Ye, Suk-Kyun Yang
    Gut and Liver.2022; 16(1): 138.     CrossRef
  • Shift to a Younger Age and Regional Differences in Inflammatory Bowel Disease in Korea: Using Healthcare Administrative Data
    Seo-Hee Kim, Yujin Park, Seong Pyo Kim, Sung Hee Lee, Seak Hee Oh, Suk-Kyun Yang, Hyung-Jin Yoon, Kyung Mo Kim
    Digestive Diseases and Sciences.2022; 67(11): 5079.     CrossRef
  • Screening and Evaluation of Probiotics for Reducing Intestinal Inflammation
    雅君 陈
    Hans Journal of Food and Nutrition Science.2022; 11(01): 44.     CrossRef
  • Development and validation of a deep learning-based algorithm for colonoscopy quality assessment
    Yuan-Yen Chang, Pai-Chi Li, Ruey-Feng Chang, Yu-Yao Chang, Siou-Ping Huang, Yang-Yuan Chen, Wen-Yen Chang, Hsu-Heng Yen
    Surgical Endoscopy.2022; 36(9): 6446.     CrossRef
  • Lycium barbarum Polysaccharides and Capsaicin Inhibit Oxidative Stress, Inflammatory Responses, and Pain Signaling in Rats with Dextran Sulfate Sodium-Induced Colitis
    Yu-Shan Chen, Yu Zhi Lian, Wen-Chao Chen, Chun-Chao Chang, Alexey A. Tinkov, Anatoly V. Skalny, Jane C.-J. Chao
    International Journal of Molecular Sciences.2022; 23(5): 2423.     CrossRef
  • Schizophrenia and risk of new‐onset inflammatory bowel disease: a nationwide longitudinal study
    Kuan‐Yi Sung, Bing Zhang, Hohui E. Wang, Ya‐Mei Bai, Shih‐Jen Tsai, Tung‐Ping Su, Tzeng‐Ji Chen, Ming‐Chih Hou, Ching‐Liang Lu, Yen‐Po Wang, Mu‐Hong Chen
    Alimentary Pharmacology & Therapeutics.2022; 55(9): 1192.     CrossRef
  • The Basic Concept of Claim Data-based Research
    Su Bee Park, Jae Myung Cha
    The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2022; 22(1): 70.     CrossRef
  • Changes in the Long-term Prognosis of Crohn’s Disease between 1986 and 2015: The Population-Based Songpa-Kangdong Inflammatory Bowel Disease Cohort Study
    Byong Duk Ye, Sung Noh Hong, Seung In Seo, Ye-Jee Kim, Jae Myung Cha, Kyoung Hoon Rhee, Hyuk Yoon, Young-Ho Kim, Kyung Ho Kim, Sun Yong Park, Seung Kyu Jeong, Ji Hyun Lee, Hyunju Park, Joo Sung Kim, Jong Pil Im, Sung Hoon Kim, Jisun Jang, Jeong Hwan Kim,
    Gut and Liver.2022; 16(2): 216.     CrossRef
  • Clinical characteristics and prognosis of amyotrophic lateral sclerosis with autoimmune diseases
    Jin-Yue Li, Xiao-Han Sun, Dong-chao Shen, Xun-Zhe Yang, Ming-Sheng Liu, Li-Ying Cui, Weidong Le
    PLOS ONE.2022; 17(4): e0266529.     CrossRef
  • The Comparative Risk of Serious Adverse Events With Tofacitinib and TNF Inhibitors in Patients With Ulcerative Colitis: The Korean Experience as Revealed by a National Database
    Gi Hyeon Seo, Sung Hoon Jung
    Journal of Korean Medical Science.2022;[Epub]     CrossRef
  • Association of young age and male sex with primary sclerosing cholangitis in Taiwanese patients with inflammatory bowel disease
    Meng-Tzu Weng, I-Lun Shih, Chien-Chih Tung, Yew-Loong Leong, Ming-Jium Shieh, Cheng-Yi Wang, Jau-Min Wong, Yen-Hsuan Ni, Shu-Chen Wei
    Intestinal Research.2022; 20(2): 224.     CrossRef
  • SARS-CoV-2 vaccination for adult patients with inflammatory bowel disease: expert consensus statement by KASID
    Yoo Jin Lee, Seong-Eun Kim, Yong Eun Park, Ji Young Chang, Hyun Joo Song, Duk Hwan Kim, Young Joo Yang, Byung Chang Kim, Jae Gon Lee, Hee Chan Yang, Miyoung Choi, Seung-Jae Myung
    Intestinal Research.2022; 20(2): 171.     CrossRef
  • Update on the epidemiology of inflammatory bowel disease in Asia: where are we now?
    Sang Hyoung Park
    Intestinal Research.2022; 20(2): 159.     CrossRef
  • Effect of smoking on the development and outcomes of inflammatory bowel disease in Taiwan: a hospital-based cohort study
    Bor-Cheng Chen, Meng-Tzu Weng, Chin-Hao Chang, Ling-Yun Huang, Shu-Chen Wei
    Scientific Reports.2022;[Epub]     CrossRef
  • Chronic bronchiectasis complicated with benign jejuno‐ileal pneumatosis intestinalis
    Sheng‐Huan Wei, Li‐Ting Huang, Tang‐Hsiu Huang
    Respirology Case Reports.2022;[Epub]     CrossRef
  • Impact of Inflammatory Bowel Disease (IBD) and IBD Medications on Risk of Hyperlipidemia and in vitro Hepatic Lipogenic-Related Gene Expression: A Population-Based Cohort Study
    Ni Tien, Tien-Yuan Wu, Cheng-Li Lin, Chia-Jui Wu, Chung-Y Hsu, Yi-Jen Fang, Yun-Ping Lim
    Frontiers in Medicine.2022;[Epub]     CrossRef
  • Personalized medicine in inflammatory bowel disease: Perspectives on Asia
    Su Hyun Park, Sang Hyoung Park
    Journal of Gastroenterology and Hepatology.2022; 37(8): 1434.     CrossRef
  • Trend and Geographic Variation in Incidence and Prevalence of Inflammatory Bowel Disease in Regions Across China: A Nationwide Employee Study Between 2013 and 2016
    Hong Yang, Runing Zhou, Xiaoyin Bai, Mingyue Guo, Gechong Ruan, Li Wang, Jiaming Qian
    Frontiers in Medicine.2022;[Epub]     CrossRef
  • Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study
    Seung Yong Shin, Soo Jung Park, Young Kim, Jong Pil Im, Hyo Jong Kim, Kang-Moon Lee, Ji Won Kim, Sung-Ae Jung, Jun Lee, Sang-Bum Kang, Sung Jae Shin, Eun Sun Kim, You Sun Kim, Tae Oh Kim, Hyun-Soo Kim, Dong Il Park, Hyung Kil Kim, Eun Soo Kim, Young-Ho Ki
    Intestinal Research.2022; 20(3): 350.     CrossRef
  • Inflammatory bowel disease in Korea: epidemiology and pathophysiology
    Jung Won Lee, Chang Soo Eun
    The Korean Journal of Internal Medicine.2022; 37(5): 885.     CrossRef
  • Lycium barbarum polysaccharides and capsaicin modulate inflammatory cytokines and colonic microbiota in colitis rats induced by dextran sulfate sodium
    Yu Zhi Lian, Chun-Chao Chang, Yu-Shan Chen, Alexey A. Tinkov, Anatoly V. Skalny, Jane C.-J. Chao
    Journal of Clinical Biochemistry and Nutrition.2022; 71(3): 229.     CrossRef
  • Radiation Exposure among Patients with Inflammatory Bowel Disease: A Single-Medical-Center Retrospective Analysis in Taiwan
    Chen-Ta Yang, Hsu-Heng Yen, Yang-Yuan Chen, Pei-Yuan Su, Siou-Ping Huang
    Journal of Clinical Medicine.2022; 11(17): 5050.     CrossRef
  • What Are the Different Phenotypes of Inflammatory Bowel Disease in Asia?
    Su Bee Park, Jin Young Yoon, Jae Myung Cha
    Gut and Liver.2022; 16(5): 676.     CrossRef
  • Dextran sodium sulfate alters antioxidant status in the gut affecting the survival of Drosophila melanogaster
    Nishal Keshav, Ramyalakshmi Ammankallu, Shashidhar, Jagdish Gopal Paithankar, Manjeshwar Shrinath Baliga, Rajashekhar K. Patil, Avinash Kundadka Kudva, Shamprasad Varija Raghu
    3 Biotech.2022;[Epub]     CrossRef
  • Ethanol Extracts of Rice Bran and Whole Grain Adlay Seeds Mitigate Colonic Inflammation and Damage in Mice with Colitis
    Hui-Chen Lo, Yu-Hsin Chen, Wen-Tzu Wu
    Nutrients.2022; 14(18): 3877.     CrossRef
  • Natural history of inflammatory bowel disease: a comparison between the East and the West
    Eun Mi Song, Suk-Kyun Yang
    Intestinal Research.2022; 20(4): 418.     CrossRef
  • Chemoprevention of Colitis-Associated Dysplasia or Cancer in Inflammatory Bowel Disease
    Shun-Wen Hsiao, Hsu-Heng Yen, Yang-Yuan Chen
    Gut and Liver.2022; 16(6): 840.     CrossRef
  • Clinical Features and Long-term Prognosis of Crohn’s Disease in Korea: Results from the Prospective CONNECT Study
    Seung Wook Hong, Byong Duk Ye, Jae Hee Cheon, Ji Hyun Lee, Ja Seol Koo, Byung Ik Jang, Kang-Moon Lee, You Sun Kim, Tae Oh Kim, Jong Pil Im, Geun Am Song, Sung-Ae Jung, Hyun Soo Kim, Dong Il Park, Hyun-Soo Kim, Kyu Chan Huh, Young-Ho Kim, Jae Myung Cha, Ge
    Gut and Liver.2022; 16(6): 907.     CrossRef
  • The epidemiology of inflammatory bowel disease in Asia and Asian immigrants to Western countries
    Satimai Aniwan, Priscila Santiago, Edward V. Loftus, Sang Hyoung Park
    United European Gastroenterology Journal.2022; 10(10): 1063.     CrossRef
  • Inflammatory bowel disease is associated with higher dementia risk: a nationwide longitudinal study
    Bing Zhang, Hohui E Wang, Ya-Mei Bai, Shih-Jen Tsai, Tung-Ping Su, Tzeng-Ji Chen, Yen-Po Wang, Mu-Hong Chen
    Gut.2021; 70(1): 85.     CrossRef
  • The four epidemiological stages in the global evolution of inflammatory bowel disease
    Gilaad G. Kaplan, Joseph W. Windsor
    Nature Reviews Gastroenterology & Hepatology.2021; 18(1): 56.     CrossRef
  • Epidemiology, burden of disease, and unmet needs in the treatment of ulcerative colitis in Asia
    Shu-Chen Wei, Jose Sollano, Yee Tak Hui, Wei Yu, Paul V. Santos Estrella, Lyndon John Q. Llamado, Nana Koram
    Expert Review of Gastroenterology & Hepatology.2021; 15(3): 275.     CrossRef
  • Clinical outcomes and long‐term prognosis of perianal Crohn's disease in an Asian population
    Eun Mi Song, Ho‐Su Lee, Ye‐Jee Kim, Eun Hye Oh, Nam Seok Ham, Jeongseok Kim, Sung Wook Hwang, Sang Hyoung Park, Dong‐Hoon Yang, Byong Duk Ye, Jeong‐Sik Byeon, Seung‐Jae Myung, Suk‐Kyun Yang
    Journal of Gastroenterology and Hepatology.2021; 36(6): 1571.     CrossRef
  • Comparison of Long-term Outcomes of Infliximab versus Adalimumab in 1,488 Biologic-Naive Korean Patients with Crohn’s Disease
    Yoon Suk Jung, Minkyung Han, Sohee Park, Jae Hee Cheon
    Gut and Liver.2021; 15(1): 92.     CrossRef
  • Incidence and Prevalence of Inflammatory Bowel Disease across Asia
    Jihye Park, Jae Hee Cheon
    Yonsei Medical Journal.2021; 62(2): 99.     CrossRef
  • Clinical features and treatment of inflammatory bowel disease in a low-incidence area
    Hsu-Heng Yen, Tsui-Chun Hsu, Mei-Wen Chen, Pei-Yuan Su, Yang-Yuan Chen
    Medicine.2021; 100(10): e25090.     CrossRef
  • The Temporal Relationships and Associations between Cutaneous Manifestations and Inflammatory Bowel Disease: A Nationwide Population-Based Cohort Study
    Yi-Teng Hung, Puo-Hsien Le, Chia-Jung Kuo, Yu-Chuan Tang, Meng-Jiun Chiou, Cheng-Tang Chiu, Chang-Fu Kuo, Yu-Huei Huang
    Journal of Clinical Medicine.2021; 10(6): 1311.     CrossRef
  • Comparison of outcomes of cyclosporine A and infliximab for steroid‐refractory acute severe ulcerative colitis
    Eun Mi Song, Eun Hye Oh, Sung Wook Hwang, Sang Hyoung Park, Dong‐Hoon Yang, Jeong‐Sik Byeon, Seung‐Jae Myung, Suk‐Kyun Yang, Byong Duk Ye
    Journal of Gastroenterology and Hepatology.2021; 36(9): 2463.     CrossRef
  • The emerging epidemic of inflammatory bowel disease in Asia and Iran by 2035: A modeling study
    Meysam Olfatifar, Mohammad Reza Zali, Mohamad Amin Pourhoseingholi, Hedieh Balaii, Shaghayegh Baradaran Ghavami, Maria Ivanchuk, Pavlo Ivanchuk, Saeed hashemi Nazari, Shabnam shahrokh, Siamak Sabour, Soheila Khodakarim, Hamid Asadzadeh Aghdaei, Pejman Roh
    BMC Gastroenterology.2021;[Epub]     CrossRef
  • Enteroscopy in Crohn’s Disease: Are There Any Changes in Role or Outcomes Over Time? A KASID Multicenter Study
    Seong Ran Jeon, Jin-Oh Kim, Jeong-Sik Byeon, Dong-Hoon Yang, Bong Min Ko, Hyeon Jeong Goong, Hyun Joo Jang, Soo Jung Park, Eun Ran Kim, Sung Noh Hong, Jong Pil Im, Seong-Eun Kim, Ja Seol Koo, Chang Soo Eun, Dong Kyung Chang
    Gut and Liver.2021; 15(3): 375.     CrossRef
  • Evaluation of non-alcoholic fatty liver disease in patients with inflammatory bowel disease using controlled attenuation parameter technology: A Taiwanese retrospective cohort study
    Hsu-Heng Yen, Pei-Yuan Su, Siou-Ping Huang, Lisha Wu, Tsui-Chun Hsu, Ya-Huei Zeng, Yang-Yuan Chen, Wan-Long Chuang
    PLOS ONE.2021; 16(5): e0252286.     CrossRef
  • Fecal microbiota profile in patients with inflammatory bowel disease in Taiwan
    Tien-En Chang, Jiing-Chyuan Luo, Ueng-Cheng Yang, Yi-Hsiang Huang, Ming-Chih Hou, Fa-Yauh Lee
    Journal of the Chinese Medical Association.2021; 84(6): 580.     CrossRef
  • Risk of Inflammatory Bowel Disease Following Appendectomy in Adulthood
    Wei-Sheng Chung, Sunny Chung, Chung-Y Hsu, Cheng-Li Lin
    Frontiers in Medicine.2021;[Epub]     CrossRef
  • Improving the care of inflammatory bowel disease (IBD) patients: perspectives and strategies for IBD center management
    Jihye Park, Sinyoung Park, Shin Ae Lee, Soo Jung Park, Jae Hee Cheon
    The Korean Journal of Internal Medicine.2021; 36(5): 1040.     CrossRef
  • Endoscopy within 7 days after detecting high calprotectin levels can be useful for therapeutic decision-making in ulcerative colitis
    Ho Min Yong, Sung-Jo Park, Seong Ran Jeon, Heesu Park, Hyun Gun Kim, Tae Hee Lee, Junseok Park, Jin-Oh Kim, Joon Seong Lee, Bong Min Ko, Hyeon Jeong Goong, Suyeon Park
    Medicine.2021; 100(34): e27065.     CrossRef
  • SARS-CoV-2 Vaccination for Adult Patients with Inflammatory Bowel Disease: Expert Consensus Statements by KASID
    Yoo Jin Lee, Seong-Eun Kim, Yong Eun Park, Ji Young Chang, Hyun Joo Song, Duk Hwan Kim, Young Joo Yang, Byung Chang Kim, Jae Gon Lee, Hee Chan Yang, Miyoung Choi, Seung-Jae Myung
    The Korean Journal of Gastroenterology.2021; 78(2): 117.     CrossRef
  • Lentinan-Based Oral Nanoparticle Loaded Budesonide With Macrophage-Targeting Ability for Treatment of Ulcerative Colitis
    Meisi Lin, Lingling Dong, Qiyan Chen, Haiting Xu, Xiaoqin Han, Ruifeng Luo, Xiulan Pu, Shanshan Qi, Wenbiao Nie, Meilin Ma, Yitao Wang, Fei Gao, Jinming Zhang
    Frontiers in Bioengineering and Biotechnology.2021;[Epub]     CrossRef
  • Short-term tolerability and effectiveness of methotrexate monotherapy in adult patients with Crohn’s disease: a retrospective study
    Hee Seung Hong, Kyuwon Kim, Kyunghwan Oh, Jae Yong Lee, Seung Wook Hong, Jin Hwa Park, Sung Wook Hwang, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Sang Hyoung Park
    Therapeutic Advances in Gastroenterology.2021;[Epub]     CrossRef
  • Treatment of inflammatory bowel diseases: focusing on 5-aminosalicylates and immunomodulators
    You Sun Kim
    Journal of the Korean Medical Association.2021; 64(9): 596.     CrossRef
  • Epidemiology and diagnosis of inflammatory bowel diseases
    Kang-Moon Lee
    Journal of the Korean Medical Association.2021; 64(9): 579.     CrossRef
  • Current status of inflammatory bowel diseases in Korea
    Suk-Kyun Yang
    Journal of the Korean Medical Association.2021; 64(9): 572.     CrossRef
  • Is the Long-term Disease Course of Elderly-Onset Ulcerative Colitis Different from That of Non-Elderly-Onset Ulcerative Colitis?
    Jin Wook Lee, Eun Soo Kim
    Gut and Liver.2021; 15(5): 639.     CrossRef
  • Association Between Ischemic Optic Neuropathy and Inflammatory Bowel Disease: A Population-Based Cohort Study in Taiwan
    Ting-Yi Lin, Yi-Fen Lai, Po-Huang Chen, Chi-Hsiang Chung, Ching-Long Chen, Yi-Hao Chen, Jiann-Torng Chen, Po-Chen Kuo, Wu-Chien Chien, Yun-Hsiu Hsieh
    Frontiers in Medicine.2021;[Epub]     CrossRef
  • Risk and characteristics of tuberculosis after anti-tumor necrosis factor therapy for inflammatory bowel disease: a hospital-based cohort study from Korea
    Jae Yong Lee, Kyunghwan Oh, Hee Seung Hong, Kyuwon Kim, Seung Wook Hong, Jin Hwa Park, Sung Wook Hwang, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Ho-Su Lee, Kyung-Wook Jo, Sang Hyoung Park
    BMC Gastroenterology.2021;[Epub]     CrossRef
  • Exploring Links Between Industrialization, Urbanization, and Chinese Inflammatory Bowel Disease
    Guanglin Cui, Hanzhe Liu, Gang Xu, Jann-Birger Laugsand, Zhigang Pang
    Frontiers in Medicine.2021;[Epub]     CrossRef
  • Endoscopic Mucosal Healing as a Treatment Target in Ulcerative Colitis: Does It Have the Same Role in Asian Patients?
    Suk-Kyun Yang, Sang Hyoung Park, Byong Duk Ye
    Gut and Liver.2021; 15(6): 942.     CrossRef
  • Capsule Endoscopy in Inflammatory Bowel Disease: When? To Whom?
    Soo-Young Na, Yun-Jeong Lim
    Diagnostics.2021; 11(12): 2240.     CrossRef
  • Biologic Use Patterns and Predictors for Non-persistence and Switching of Biologics in Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Study
    Yoon Suk Jung, Minkyung Han, Sohee Park, Jae Hee Cheon
    Digestive Diseases and Sciences.2020; 65(5): 1436.     CrossRef
  • Crohn’s disease and ulcerative colitis are associated with different lipid profile disorders: a nationwide population‐based study
    Hosim Soh, Jong Pil Im, Kyungdo Han, Seona Park, Seung Wook Hong, Jeong Min Moon, Eun Ae Kang, Jaeyoung Chun, Hyun Jung Lee, Joo Sung Kim
    Alimentary Pharmacology & Therapeutics.2020; 51(4): 446.     CrossRef
  • The epidemiology of inflammatory bowel disease: East meets west
    Wing Yan Mak, Mirabella Zhao, Siew Chien Ng, Johan Burisch
    Journal of Gastroenterology and Hepatology.2020; 35(3): 380.     CrossRef
  • Comparison of Real-World Outcomes of Infliximab versus Adalimumab in Biologic-Naïve Korean Patients with Ulcerative Colitis: A Population-Based Study
    Minkyung Han, Yoon Suk Jung, Jae Hee Cheon, Sohee Park
    Yonsei Medical Journal.2020; 61(1): 48.     CrossRef
  • A case with cytomegalovirus colitis and toxic megacolon initially diagnosed as Crohn's disease
    Shan-Han Chang, Hsin-Yun Sun, Chia-Tung Shun, Shu-Chen Wei
    Journal of the Formosan Medical Association.2020; 119(9): 1442.     CrossRef
  • Trends in Healthcare Costs for Inflammatory Bowel Disease in South Korea
    Yoon Suk Jung
    Gut and Liver.2020; 14(1): 3.     CrossRef
  • Cost‐effectiveness analysis of fecal microbiota transplantation for recurrent Clostridium difficile infection in patients with inflammatory bowel disease
    Joyce H S You, Xinchan Jiang, Wally H Lee, Paul K S Chan, Siew C Ng
    Journal of Gastroenterology and Hepatology.2020; 35(9): 1515.     CrossRef
  • Crohn’s disease
    Giulia Roda, Siew Chien Ng, Paulo Gustavo Kotze, Marjorie Argollo, Remo Panaccione, Antonino Spinelli, Arthur Kaser, Laurent Peyrin-Biroulet, Silvio Danese
    Nature Reviews Disease Primers.2020;[Epub]     CrossRef
  • Revisiting Inflammatory Bowel Disease: Pathology, Treatments, Challenges and Emerging Therapeutics Including Drug Leads from Natural Products
    Karma Yeshi, Roland Ruscher, Luke Hunter, Norelle L. Daly, Alex Loukas, Phurpa Wangchuk
    Journal of Clinical Medicine.2020; 9(5): 1273.     CrossRef
  • Predictive values of stool-based tests for mucosal healing among Taiwanese patients with ulcerative colitis: a retrospective cohort analysis
    Hsu-Heng Yen, Mei-Wen Chen, Yu-Yao Chang, Hsuan-Yuan Huang, Tsui-Chun Hsu, Yang-Yuan Chen
    PeerJ.2020; 8: e9537.     CrossRef
  • Association between inflammatory bowel disease and bullous pemphigoid: a population-based case–control study
    Yi-Ju Chen, Chao-Kuei Juan, Yun-Ting Chang, Chun-Ying Wu, Hsiu J. Ho, Hsiao-Ching Tseng
    Scientific Reports.2020;[Epub]     CrossRef
  • Lactobacilli and bifidobacteria derived from infant intestines may activate macrophages and lead to different IL-10 secretion
    Huijing Liang, Zihao Luo, Zhonghua Miao, Xi Shen, Ming Li, Xuguang Zhang, Jiehua Chen, Xiaolei Ze, Qiwei Chen, Fang He
    Bioscience, Biotechnology, and Biochemistry.2020; 84(12): 2558.     CrossRef
  • Temporal trend of disease recognition, treatment paradigm, and clinical outcomes of Crohn disease in Thailand from 2000 through 2017
    Julajak Limsrivilai, Satimai Aniwan, Asawin Sudcharoen, Natapat Chaisidhivej, Piyaphan Prueksapanich, Nonthalee Pausawasdi, Phunchai Charatcharoenwitthaya, Supot Pongprasobchai, Sathaporn Manassatit
    Medicine.2020; 99(38): e22216.     CrossRef
  • Combination of Lactobacillus acidophilus and Bifidobacterium animalis subsp. lactis Shows a Stronger Anti-Inflammatory Effect than Individual Strains in HT-29 Cells
    Sing-Chung Li, Wei-Fang Hsu, Jung-Su Chang, Chun-Kuang Shih
    Nutrients.2019; 11(5): 969.     CrossRef
  • Risk of immune-mediated inflammatory diseases in newly diagnosed ankylosing spondylitis patients: a population-based matched cohort study
    Hsin-Hua Chen, Wen-Cheng Chao, Yi-Hsing Chen, Tsu-Yi Hsieh, Kuo-Lung Lai, Yi-Ming Chen, Wei-Ting Hung, Ching-Tsai Lin, Chih-Wei Tseng, Ching-Heng Lin
    Arthritis Research & Therapy.2019;[Epub]     CrossRef
  • Comparison of outcomes of continuation/discontinuation of 5-aminosalicylic acid after initiation of anti-tumor necrosis factor-alpha therapy in patients with inflammatory bowel disease
    Youn I Choi, Tae Jun Kim, Dong Kyun Park, Jun-won Chung, Kyoung Oh Kim, Kwang An Kwon, Yoon Jae Kim
    International Journal of Colorectal Disease.2019; 34(10): 1713.     CrossRef
  • Microscopic features of small bowel mucosa of patients with Crohn’s disease
    Yun Cui, Shi-yuan Lu, Jie Xu, Yan-shen Peng, Qi Miao, Xiao-qing Wang, Xiao-yu Chen, Zhi-hua Ran
    BMC Gastroenterology.2019;[Epub]     CrossRef
  • 13,645 View
  • 523 Download
  • 112 Web of Science
  • 109 Crossref
Close layer
IBD
Experience of patients with inflammatory bowel disease in using a home fecal calprotectin test as an objective reported outcome for self-monitoring
Shu-Chen Wei, Chien-Chih Tung, Meng-Tzu Weng, Jau-Min Wong
Intest Res 2018;16(4):546-553.   Published online October 10, 2018
DOI: https://doi.org/10.5217/ir.2018.00052
AbstractAbstract PDFPubReaderePub
Background/Aims
Fecal calprotectin (fC) level is a predictive marker of mucosal healing for patients with inflammatory bowel disease (IBD). Home fC tests are now available. We evaluated the performance of the smartphone-based IBDoc home testing system in patients with IBD and obtained their feedback as an objective patient-reported outcome.
Methods
This prospective study enrolled consecutive patients with IBD in clinical remission. fC in the same stool sample was assessed by using both the laboratory test (Quantum Blue calprotectin test) and home test (IBDoc). The correlation between the 2 tests was analyzed using the Pearson method. In addition, the patients were asked to fill a questionnaire based on their experience.
Results
Fifty-one patients with IBD (68 tests and 49 questionnaires) were included. The correlation between Quantum Blue test and IBDoc was good (r=0.776, P<0.0001). After the test, 56% patients found IBDoc easy to perform, and 96% were satisfied with it. Thirty-nine patients (80%) had a strong (>70%) probability to use it for future monitoring if the price was acceptable. By using 250 μg/g as the cutoff, the agreement between home test and laboratory results was 80%, and by using 600 μg/g as the cutoff, the agreement increased to 92%.
Conclusions
The correlation between the laboratory and home tests was good. Most patients found the home test to be feasible and easy to use and preferred it over laboratory test and endoscopy for monitoring. Therefore, the home test could be used as an objective patient-reported outcome.

Citations

Citations to this article as recorded by  
  • Performance evaluation of a smartphone-based home test for fecal calprotection
    Simon Michaelis, Anna Hochfellner, Christopher Schneider, Wolfgang J. Schnedl, Andreas Baranyi, Dietmar Enko
    Clinical Chemistry and Laboratory Medicine (CCLM).2025; 63(1): 139.     CrossRef
  • Blood self-sampling: friend or foe?
    Mario Plebani
    Clinical Chemistry and Laboratory Medicine (CCLM).2025; 63(1): 1.     CrossRef
  • Limitations in real-world telemonitoring applicability in gastroenterology and hepatology: a systematic review
    Aditi Kumar, Kohi Gananandan, Guy Robinson, Jennie Clough, Oliver D Tavabie
    Frontline Gastroenterology.2025; : flgastro-2024-102997.     CrossRef
  • Validation of rapid fecal calprotectin assay using particle enhanced turbidimetric immunoassay for inflammatory bowel disease
    Akihiko Oka, Kousaku Kawashima, Kenichi Kishimoto, Satoshi Kotani, Mai Fukunaga, Nobuhiko Fukuba, Yoshiyuki Mishima, Naoki Oshima, Norihisa Ishimura, Muyiwa Awoniyi, Shunji Ishihara
    Scientific Reports.2024;[Epub]     CrossRef
  • iSTART-II: An Update on the i Support Therapy–Access to Rapid Treatment (iSTART) Approach for Patient-Centered Therapy in Mild-to-Moderate Ulcerative Colitis
    Ferdinando D’Amico, Fernando Magro, Benedicte Caron, Axel Dignass, Vipul Jairath, Ailsa Hart, Paulo Gustavo Kotze, Kristine Paridaens, Sameer Al Awadhi, Taku Kobayashi, Britta Siegmund, Laurent Peyrin-Biroulet, Silvio Danese
    Journal of Clinical Medicine.2023; 12(3): 1142.     CrossRef
  • Point-of-Care Testing and Home Testing: Pragmatic Considerations for Widespread Incorporation of Stool Tests, Serum Tests, and Intestinal Ultrasound
    Rune Wilkens, Michael Dolinger, Johan Burisch, Christian Maaser
    Gastroenterology.2022; 162(5): 1476.     CrossRef
  • Post-neonatal Outcomes of Infants Born to Women with Active Trimester One Inflammatory Bowel Disease: A Pilot Study
    Richard Y. Wu, Parul Tandon, Lindsy Ambrosio, Garett Dunsmore, Naomi Hotte, Levinus A. Dieleman, Shokrollah Elahi, Karen Madsen, Vivian Huang
    Digestive Diseases and Sciences.2022; 67(11): 5177.     CrossRef
  • Inflammatory bowel disease biomarkers
    Dandan Liu, Varma Saikam, Katie A. Skrada, Didier Merlin, Suri S. Iyer
    Medicinal Research Reviews.2022; 42(5): 1856.     CrossRef
  • Urine and Serum Metabolomic Profiles Differ by Disease Activity in Pregnant Women With Inflammatory Bowel Diseases
    Richard Y. Wu, Parul Tandon, Joyce S. Oh, Lindsy Ambrosio, Naomi Hotte, Binal Shah-Gandhi, Karen L. Madsen, Levinus A. Dieleman, Shokrollah Elahi, Karen I. Kroeker, Vivian Huang
    Gastro Hep Advances.2022; 1(6): 993.     CrossRef
  • Elevated IL-6 and IL-22 in Early Pregnancy Are Associated with Worse Disease Course in Women with Inflammatory Bowel Disease
    Richard Y. Wu, Karren Xiao, Naomi Hotte, Parul Tandon, Yesmine Elloumi, Lindsy Ambrosio, Garett Dunsmore, Shokrollah Elahi, Karen I. Kroeker, Levinus A. Dieleman, Karen L. Madsen, Vivian Huang
    International Journal of Molecular Sciences.2022; 23(18): 10281.     CrossRef
  • Self-monitoring with home based fecal calprotectin is associated with increased medical treatment. A randomized controlled trial on patients with inflammatory bowel disease
    Isak Östlund, Mårten Werner, Pontus Karling
    Scandinavian Journal of Gastroenterology.2021; 56(1): 38.     CrossRef
  • How to manage inflammatory bowel disease during the COVID-19 pandemic: A guide for the practicing clinician
    Júlio Maria Fonseca Chebli, Natália Sousa Freitas Queiroz, Adérson Omar Mourão Cintra Damião, Liliana Andrade Chebli, Márcia Henriques de Magalhães Costa, Rogério Serafim Parra
    World Journal of Gastroenterology.2021; 27(11): 1022.     CrossRef
  • International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases
    Ferdinando D'Amico, David T. Rubin, Paulo Gustavo Kotze, Fernando Magro, Britta Siegmund, Taku Kobayashi, Pablo A. Olivera, Peter Bossuyt, Lieven Pouillon, Edouard Louis, Eugeni Domènech, Subrata Ghosh, Silvio Danese, Laurent Peyrin‐Biroulet
    United European Gastroenterology Journal.2021; 9(4): 451.     CrossRef
  • A Patient Self-Made Point-of-Care Fecal Test Improves Diagnostic Accuracy Compared with Fecal Calprotectin Alone in Inflammatory Bowel Disease Patients
    Gonzalo Hijos-Mallada, Raul Velamazán, Raúl Marti, Eduardo Chueca, Samantha Arechavaleta, Alberto Lué, Fernando Gomollón, Angel Lanas, Carlos Sostres
    Diagnostics.2021; 11(12): 2323.     CrossRef
  • Real-life utility and diagnostic accuracy of a home-performed fecal calprotectin test to predict endoscopic activity in patients with inflammatory bowel disease under maintenance treatment with adalimumab
    Eleni Orfanoudaki, Ioannis Drygiannakis, Eirini Theodoraki, Kalliopi Foteinogiannopoulou, Aikaterini Mantaka, Ioannis E. Koutroubakis
    European Journal of Gastroenterology & Hepatology.2021; 33(1S): e777.     CrossRef
  • Fecal calprotectin predicts complete mucosal healing in patients with ulcerative colitis: Systematic review and meta‑analysis
    Zhongsheng Cao, Chenglong Ye, Lunan Li, Xiaoge Geng, Wensheng Pan, Jiyong Jing
    World Academy of Sciences Journal.2021;[Epub]     CrossRef
  • The effect of a mindfulness-based therapy on different biomarkers among patients with inflammatory bowel disease: a randomised controlled trial
    Rafael González-Moret, Ausias Cebolla, Xavier Cortés, Rosa M. Baños, Jaime Navarrete, José Enrique de la Rubia, Juan Francisco Lisón, José Miguel Soria
    Scientific Reports.2020;[Epub]     CrossRef
  • Biochemical Biomarkers of Mucosal Healing for Inflammatory Bowel Disease in Adults
    Małgorzata Krzystek-Korpacka, Radosław Kempiński, Mariusz Bromke, Katarzyna Neubauer
    Diagnostics.2020; 10(6): 367.     CrossRef
  • What is the appropriate cut-off value of CRP to predict endoscopic remission in patients with ulcerative colitis in clinical remission?
    Jongbeom Shin, Sung Min Kong, Gyeol Seong, Young-Ho Kim
    International Journal of Colorectal Disease.2020; 35(12): 2249.     CrossRef
  • Setting up a Virtual Calprotectin Clinic in Inflammatory Bowel Diseases: Literature Review and Nancy Experience
    Ferdinando D’Amico, Patrick Netter, Cedric Baumann, Muriel Veltin, Camille Zallot, Isabelle Aimone-Gastin, Silvio Danese, Laurent Peyrin-Biroulet
    Journal of Clinical Medicine.2020; 9(9): 2697.     CrossRef
  • Calprotectin in inflammatory bowel disease
    Fatemeh Khaki-Khatibi, Durdi Qujeq, Mehrdad Kashifard, Soheila Moein, Mahmood Maniati, Mostafa Vaghari-Tabari
    Clinica Chimica Acta.2020; 510: 556.     CrossRef
  • Remote Monitoring Empowerment of Patients with IBDs during the SARS-CoV-2 Pandemic
    Mauro Mastronardi, Margherita Curlo, Maurizio Polignano, Natalino Vena, Daniela Rossi, Gianluigi Giannelli
    Healthcare.2020; 8(4): 377.     CrossRef
  • Usability of IBDoc, a Novel Fecal Calprotectin Home-Based Rapid Test in Clinical Practice
    Mia Jülke Røer, Milada Cvancarova Småstuen, Arne Gustav Røseth
    Point of Care: The Journal of Near-Patient Testing & Technology.2019; 18(3): 85.     CrossRef
  • POCT system for the fecal calprotectin detection in the telemonitoring of patients with inflammatory bowel disease
    K Malíčková, V Pešinová, M Kolář, M Lukáš
    Klinická biochemie a metabolismus.2019; 27(2): 72.     CrossRef
  • Home-based fecal calprotectin test is expected to play an important role in patients with inflammatory bowel diseases
    Young-Ho Kim
    Intestinal Research.2018; 16(4): 507.     CrossRef
  • 12,201 View
  • 180 Download
  • 25 Web of Science
  • 25 Crossref
Close layer
IBD
Should Asian inflammatory bowel disease patients need routine thromboprophylaxis?
Meng-Tzu Weng, Chien-Chih Tung, Jau-Min Wong, Shu-Chen Wei
Intest Res 2018;16(2):312-314.   Published online April 30, 2018
DOI: https://doi.org/10.5217/ir.2018.16.2.312
PDFPubReaderePub

Citations

Citations to this article as recorded by  
  • Perioperative optimization of Crohn's disease
    Chun‐Chi Lin, Hung‐Hsin Lin, Hui‐Chuen Chen, Nai‐Chia Chen, I‐Lun Shih, Ji‐Shiang Hung, Te‐Cheng Yueh, Feng‐Fan Chiang, Ping‐Wei Lin, Yuan‐Yao Tsai, Shu‐Chen Wei
    Annals of Gastroenterological Surgery.2023; 7(1): 10.     CrossRef
  • Risk of venous thromboembolism with a central venous catheter in hospitalized Japanese patients with inflammatory bowel disease: a propensity score-matched cohort study
    Yasuhiro Aoki, Hiroki Kiyohara, Yohei Mikami, Kosaku Nanki, Takaaki Kawaguchi, Yusuke Yoshimatsu, Shinya Sugimoto, Tomohisa Sujino, Kaoru Takabayashi, Naoki Hosoe, Haruhiko Ogata, Yasushi Iwao, Takanori Kanai
    Intestinal Research.2023; 21(3): 318.     CrossRef
  • Incidence and risk factors for venous thrombosis among patients with inflammatory bowel disease in China: a multicenter retrospective study
    Jing Liu, Xiang Gao, Ye Chen, Qiao Mei, Liangru Zhu, Jiaming Qian, Pinjin Hu, Qian Cao
    Intestinal Research.2021; 19(3): 313.     CrossRef
  • Trends and risk factors of mortality analysis in patients with inflammatory bowel disease: a Taiwanese nationwide population-based study
    Wei-Chen Lin, Meng-Tzu Weng, Chien-Chih Tung, Yuan-Ting Chang, Yew-Loong Leong, Yu-Ting Wang, Horng-Yuan Wang, Jau-Min Wong, Shu-Chen Wei
    Journal of Translational Medicine.2019;[Epub]     CrossRef
  • 5,399 View
  • 66 Download
  • 4 Web of Science
  • 4 Crossref
Close layer
Intestinal Stricture in Crohn's Disease
Chen-Wang Chang, Jau-Min Wong, Chien-Chih Tung, I-Lun Shih, Horng-Yuan Wang, Shu-Chen Wei
Intest Res 2015;13(1):19-26.   Published online January 29, 2015
DOI: https://doi.org/10.5217/ir.2015.13.1.19
AbstractAbstract PDFPubReader

Crohn's disease (CD) is a disease with chronic inflammation of unknown etiology involving any part of the gastrointestinal tract. The incidence and prevalence of CD are increasing recently in Asia. Half of the CD patients will have intestinal complications, such as strictures or fistulas, within 20 years after diagnosis. Twenty-five percentage of CD patients have had at least one small bowel stricture and 10% have had at least one colonic stricture and lead to significant complications. Most of these patients will require at least one surgery during their lifetime. Early diagnosis and evaluation with adequate managements for the patients can prevent disability and mortality of these patient. Here, we reviewed the current incidence of CD with stricture, the etiology of stricture, and how to diagnose and manage the stricture.

Citations

Citations to this article as recorded by  
  • Colonic strictures in Crohn’s disease: a non-surgical survival
    Sarra Laabidi, Hamed Aboubecrine, Salma Souissi, Donia Gouiaa, Asma Labidi, Nadia Ben Mustapha, Anis Haddad, Amine Sebai, Meriem Serghini, Monia Fekih, Hanene Jaziri, Jalel Boubaker
    Future Science OA.2025;[Epub]     CrossRef
  • Enteroscopic Balloon Dilation in Small Bowel Stricturing Crohn’s Disease: Long‐Term Outcomes and Risk Factors for Surgery in a Single‐Center Prospective Observational Study
    Sung Noh Hong, Ji Eun Kim, Eun Ran Kim, Dong Kyung Chang, Young‐Ho Kim
    United European Gastroenterology Journal.2025;[Epub]     CrossRef
  • MicroRNA Sequencing of Serum Exosomes Reveals miR205-5p as an Anti-Fibrogenic Factor Against Intestinal Fibrosis in Crohn’s Disease
    Ying Xie, Mieke van Daelen, Rebecca Park, Isabella Almaraz, Lindsey Fontenot, Florian Rieder, Wendy Ho, Berkeley Limketkai, David Q. Shih, Minjie Wei, Yiling Li, Hon Wai Koon
    International Journal of Molecular Sciences.2025; 26(8): 3778.     CrossRef
  • Duodenal Crohn’s disease: Case report and systematic review
    Muniratu Amadu, Jonathan Soldera
    World Journal of Methodology.2024;[Epub]     CrossRef
  • Infective Endocarditis After Endoscopic Stricture Dilation in Crohn's Disease
    André Gonçalves, Sandra Barbeiro, Carina Leal, Antonieta Santos, Helena Vasconcelos
    ACG Case Reports Journal.2024; 11(6): e01377.     CrossRef
  • Association between nutritional status assessed by body mass index and Crohn's disease phenotype: A Nation-wide analysis
    Judwin Ndzo, Sudheer K. Vuyyuru, Thomas Trimble, Kaung Yan, Grazziela Figueredo, Gordon W. Moran
    Clinical Nutrition ESPEN.2024; 64: 290.     CrossRef
  • Perioperative optimization of Crohn's disease
    Chun‐Chi Lin, Hung‐Hsin Lin, Hui‐Chuen Chen, Nai‐Chia Chen, I‐Lun Shih, Ji‐Shiang Hung, Te‐Cheng Yueh, Feng‐Fan Chiang, Ping‐Wei Lin, Yuan‐Yao Tsai, Shu‐Chen Wei
    Annals of Gastroenterological Surgery.2023; 7(1): 10.     CrossRef
  • Treatment escalation and de-escalation decisions in Crohn’s disease: Delphi consensus recommendations from Japan, 2021
    Hiroshi Nakase, Motohiro Esaki, Fumihito Hirai, Taku Kobayashi, Katsuyoshi Matsuoka, Minoru Matsuura, Makoto Naganuma, Masayuki Saruta, Kiichiro Tsuchiya, Motoi Uchino, Kenji Watanabe, Tadakazu Hisamatsu, Akira Andoh, Shigeki Bamba, Motohiro Esaki, Mikihi
    Journal of Gastroenterology.2023; 58(4): 313.     CrossRef
  • Ileocecal valve that cannot be intubated in Crohn’s disease: is this a sign of poor prognosis?
    Muhammed Bahaddin Durak, Cem Simsek, Bayram İnan, Ilhami Yuksel
    International Journal of Colorectal Disease.2023;[Epub]     CrossRef
  • Effects of Mimosa caesalpiniifolia pre-formulation on the intestinal barrier during sodium dextran sulfate-induced colitis in Wistar rats
    Aline Garnevi-Fávero , Karina Nascimento-da Silva , Willian Rodrigues-Ribeiro , Caroline Marcantonio-Ferreira , Patrícia Sartorelli, Leonardo Cardili, Rita De Cássia-Sinigaglia , Joice Naiara Bertaglia-Pereira, Marcelo Aparecido-da Silva , Wagner Vilega
    Biomédica.2023; 43(2): 282.     CrossRef
  • Small Bowel Imaging from Stepchild of Roentgenology to MR Enterography: Part I: Guidance in Performing and Observing Normal and Abnormal Imaging Findings
    Antonio Pierro, Laura Maria Minordi, Luigi Larosa, Giulia Guerri, Alessandro Grimaldi, Fabio Quinto, Fabio Rotondi, Annalisa Marcellino, Teresa Bevere, Raffaella Basilico, Roberto Iezzi, Savino Cilla
    Life.2023; 13(8): 1691.     CrossRef
  • Small Bowel Imaging from Stepchild of Roentgenology to MR Enterography, Part II: The Reliable Disclosure of Crohn’s Disease and Non-Inflammatory Small Bowel Disorder Plot through MRI Findings
    Antonio Pierro, Laura Maria Minordi, Luigi Larosa, Carla Cipri, Giulia Guerri, Fabio Quinto, Fabio Rotondi, Annalisa Marcellino, Raffaella Basilico, Roberto Iezzi, Savino Cilla
    Life.2023; 13(9): 1836.     CrossRef
  • Use of oral diet and nutrition support in management of stricturing and fistulizing Crohn's disease
    Kush Fansiwala, Neha D. Shah, Kelly A. McNulty, Mary R. Kwaan, Berkeley N. Limketkai
    Nutrition in Clinical Practice.2023; 38(6): 1282.     CrossRef
  • Congenital Partial Colonic Agenesis in Dogs and Cats: Clinical, Biological, Diagnostic Imaging, Endoscopic and Histopathologic Characterization, a Retrospective Study
    Paul Remmel, Lucile Gros, Jérémy Mortier, Valérie Freiche
    Veterinary Sciences.2023; 10(9): 577.     CrossRef
  • Revisiting fibrosis in inflammatory bowel disease: the gut thickens
    Silvia D’Alessio, Federica Ungaro, Daniele Noviello, Sara Lovisa, Laurent Peyrin-Biroulet, Silvio Danese
    Nature Reviews Gastroenterology & Hepatology.2022; 19(3): 169.     CrossRef
  • Medical treatment of intestinal Crohn's disease
    Eula Plana Tetangco, Adam C. Stein
    Seminars in Colon and Rectal Surgery.2022; 33(1): 100862.     CrossRef
  • Choosing the right biologic for complications of inflammatory bowel disease
    Shana Rakowsky, Konstantinos Papamichael, Adam S. Cheifetz
    Expert Review of Gastroenterology & Hepatology.2022; 16(3): 235.     CrossRef
  • The Possible Pathogenic Role of IgG4-Producing Plasmablasts in Stricturing Crohn’s Disease
    Omar Bushara, David Joseph Escobar, Samuel Edward Weinberg, Leyu Sun, Jie Liao, Guang-Yu Yang
    Pathobiology.2022; 89(4): 187.     CrossRef
  • Safety and efficacy of non-fluoroscopic endoscopic dilatation of gastrointestinal tuberculosis related strictures
    Pankaj Kumar, Anuraag Jena, Chhagan Lal Birda, Harjeet Singh, Pankaj Gupta, Kaushal Kishor Prasad, Usha Dutta, Vishal Sharma
    BMC Gastroenterology.2022;[Epub]     CrossRef
  • Endoscopic balloon dilations for strictures of rectum, ileocecal valve and duodenum in a patient with X-linked inhibitor of apoptosis deficiency: a case report
    Shinsuke Otagiri, Takehiko Katsurada, Kensuke Sakurai, Junichi Sugita, Naoya Sakamoto
    Intestinal Research.2022; 20(2): 274.     CrossRef
  • State-of-the-art surgery for Crohn’s disease: Part II—colonic Crohn’s disease and associated neoplasms
    Anne Macleod, Sandra L. Kavalukas, Katharina M. Scheurlen, Susan Galandiuk
    Langenbeck's Archives of Surgery.2022; 407(7): 2595.     CrossRef
  • The role of interleukin-33 in organ fibrosis
    Samuele Di Carmine, Molly M Scott, Mairi H McLean, Henry J McSorley
    Discovery Immunology.2022;[Epub]     CrossRef
  • Late onset crohns ileitis—A diagnostic dilemma
    Ashok Sunder, Manish Kumar, Sudip Saha, Bhagyalakshmi Satyanarayan
    Journal of Family Medicine and Primary Care.2022; 11(12): 7968.     CrossRef
  • Inhibition of APE1/Ref-1 Redox Signaling Alleviates Intestinal Dysfunction and Damage to Myenteric Neurons in a Mouse Model of Spontaneous Chronic Colitis
    Lauren Sahakian, Rhiannon T Filippone, Rhian Stavely, Ainsley M Robinson, Xu Sean Yan, Raquel Abalo, Rajaraman Eri, Joel C Bornstein, Mark R Kelley, Kulmira Nurgali
    Inflammatory Bowel Diseases.2021; 27(3): 388.     CrossRef
  • A postdischarge venous thromboembolism risk calculator for inflammatory bowel disease surgery
    Cary Jo R. Schlick, Tarik K. Yuce, Anthony D. Yang, Michael F. McGee, David J. Bentrem, Karl Y. Bilimoria, Ryan P. Merkow
    Surgery.2021; 169(2): 240.     CrossRef
  • Presence of Obstructive Symptoms and Absence of Perianal Crohn Disease Is Predictive of Surgery After Endoscopic Balloon Dilation
    Barathi Sivasailam, Scott Manski, Alicia Wentz, Raymond K Cross
    Inflammatory Bowel Diseases.2021; 27(8): 1230.     CrossRef
  • Association of Baseline Luminal Narrowing With Ileal Microbial Shifts and Gene Expression Programs and Subsequent Transmural Healing in Pediatric Crohn Disease
    Allison D Ta, Nicholas J Ollberding, Rebekah Karns, Yael Haberman, Adina L Alazraki, David Hercules, Robert Baldassano, James Markowitz, Melvin B Heyman, Sandra Kim, Barbara Kirschner, Jason M Shapiro, Joshua Noe, Maria Oliva-Hemker, Anthony Otley, Marian
    Inflammatory Bowel Diseases.2021; 27(11): 1707.     CrossRef
  • Infliximab therapy intensification based on endoscopic activity is related to suppress treatment discontinuation in patients with Crohn disease
    Yuga Komaki, Shuji Kanmura, Kazuki Yutsudo, Kosuke Kuwazuru, Fukiko Komaki, Akihito Tanaka, Nobuaki Nishimata, Yoichi Sameshima, Fumisato Sasaki, Hidehisa Ohi, Yuichi Nakamura, Koichi Tokushige, Yukinori Sameshima, Akio Ido
    Medicine.2021; 100(6): e24731.     CrossRef
  • Duodenal Obstruction in a Patient Previously Treated With EndoVascular Aneurysm Sealing System Repair
    Carlo Biddau, Carlo Nagliati, Michele Graziano, Lorenzo Cereser, Giovanni Terrosu, Alessandro Balani
    Vascular and Endovascular Surgery.2021; 55(8): 859.     CrossRef
  • Crohn's Disease Obstructions
    Molly M. Ford
    Clinics in Colon and Rectal Surgery.2021; 34(04): 227.     CrossRef
  • Transplantation of fecal microbiota from patients with inflammatory bowel disease and depression alters immune response and behavior in recipient mice
    Hyo-Min Jang, Jeon-Kyung Kim, Min-Kyung Joo, Yoon-Jung Shin, Chang Kyun Lee, Hyo-Jong Kim, Dong-Hyun Kim
    Scientific Reports.2021;[Epub]     CrossRef
  • Crohn’s disease at radiological imaging: focus on techniques and intestinal tract
    Giuseppe Cicero, Silvio Mazziotti
    Intestinal Research.2021; 19(4): 365.     CrossRef
  • Current Topics of the Mechanism of Intestinal Fibrosis in Crohn’s Disease
    Yusuke Honzawa, Shuji Yamamoto, Makoto Okabe, Hiroshi Seno, Hiroshi Nakase
    Immuno.2021; 1(4): 574.     CrossRef
  • Worse outcomes and higher costs of care in fibrostenotic Crohn’s disease: a real-world propensity-matched analysis in the USA
    Melody Dehghan, Gabriel Wong, Edward Neuberger, Cindy Kin, Florian Rieder, K T Park
    BMJ Open Gastroenterology.2021; 8(1): e000781.     CrossRef
  • Epidemiology of fibrostenosing inflammatory bowel disease
    Joyce Wing Yan Mak, Siew Chien Ng
    Journal of Digestive Diseases.2020; 21(6): 332.     CrossRef
  • The Efficacy of Anti-Tumor Necrosis Factor Alpha for Symptomatic Stricturing Small Bowel Crohn’s Disease
    Mansour Alourfi, Mahmoud Mosli, Omar I Saadah
    Cureus.2020;[Epub]     CrossRef
  • Roles of protein ubiquitination in inflammatory bowel disease
    Yue Xiao, Qi Huang, Zherui Wu, Weilin Chen
    Immunobiology.2020; 225(6): 152026.     CrossRef
  • Chirurgie des maladies inflammatoires chroniques de l’intestin
    M. Aubert, D. Mege, L. Maggiori, Y. Panis
    EMC - Gastro-entérologie.2020; 37(3): 1.     CrossRef
  • Development, validation, and application of a novel tool to measure disease-related knowledge in patients with inflammatory bowel disease
    Hyuk Yoon, Suk-Kyun Yang, Hoonsub So, Ko Eun Lee, Sang Hyoung Park, Sung-Ae Jung, Joong Haeng Choh, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee
    The Korean Journal of Internal Medicine.2019; 34(1): 81.     CrossRef
  • Unusual causes of large bowel obstruction
    Nicholas G. Farkas, Ted Joseph P. Welman, Talisa Ross, Sarah Brown, Jason J. Smith, Nikhil Pawa
    Current Problems in Surgery.2019; 56(2): 49.     CrossRef
  • TTC7A: Steward of Intestinal Health
    Sasha Jardine, Neel Dhingani, Aleixo M. Muise
    Cellular and Molecular Gastroenterology and Hepatology.2019; 7(3): 555.     CrossRef
  • Segmental dilatation following side‐to‐side isoperistaltic strictureplasty in Crohn’s disease: a note of caution
    Brendan Desmond, Ashok Gunawardene, Ben Griffiths, John Keating
    ANZ Journal of Surgery.2019;[Epub]     CrossRef
  • Small bowel strictures
    Deniz Durmush, Arthur J. Kaffes
    Current Opinion in Gastroenterology.2019; 35(3): 235.     CrossRef
  • Early Initiation of Anti-TNF is Associated with Favourable Long-term Outcome in Crohn’s Disease: 10-Year-Follow-up Data from the Swiss IBD Cohort Study
    Roy Frei, Nicolas Fournier, Jonas Zeitz, Michael Scharl, Bernhard Morell, Thomas Greuter, Philipp Schreiner, Benjamin Misselwitz, Ekaterina Safroneeva, Alain M Schoepfer, Stephan R Vavricka, Gerhard Rogler, Luc Biedermann
    Journal of Crohn's and Colitis.2019; 13(10): 1292.     CrossRef
  • Clinical Features and Prognosis of Crohn’s Disease with Upper Gastrointestinal Tract Phenotype in Chinese Patients
    Xiao-Wei Sun, Juan Wei, Zhao Yang, Xin-Xin Jin, Hai-Jun Wan, Bo-Si Yuan, Miao-Fang Yang, Jiong Liu, Fang-Yu Wang
    Digestive Diseases and Sciences.2019; 64(11): 3291.     CrossRef
  • Phosphatidylinositol 3-kinase p110δ drives intestinal fibrosis in SHIP deficiency
    Young Lo, Jean Philippe Sauve, Susan C. Menzies, Theodore S. Steiner, Laura M. Sly
    Mucosal Immunology.2019; 12(5): 1187.     CrossRef
  • Occult Adenocarcinoma Arising in Crohn’s-Related Strictures: A Case Series
    Kevin Singh, Amandeep Singh, Jessica Philpott, David Liska, Keith Lai
    Crohn's & Colitis 360.2019;[Epub]     CrossRef
  • Agentes anti-factor de necrosis tumoral en enfermedad de Crohn y colitis ulcerosa: más allá de la enfermedad luminal
    Laura Núñez-Gómez, Francisco Mesonero-Gismero, Agustín Albillos-Martínez, Antonio López-Sanromán
    Gastroenterología y Hepatología.2018; 41(9): 576.     CrossRef
  • Parathyroid Hormone–Like Hormone Induces Epithelial-to-Mesenchymal Transition of Intestinal Epithelial Cells by Activating the Runt-Related Transcription Factor 2
    Shuying He, Minmin Xue, Cuiping Liu, Fang Xie, Lan Bai
    The American Journal of Pathology.2018; 188(6): 1374.     CrossRef
  • Anti-tumour necrosis factor agents in Crohn's disease and ulcerative colitis: Beyond luminal disease
    Laura Núñez-Gómez, Francisco Mesonero-Gismero, Agustín Albillos-Martínez, Antonio López-Sanromán
    Gastroenterología y Hepatología (English Edition).2018; 41(9): 576.     CrossRef
  • Long-Term Outcomes of Endoscopic Balloon Dilation for Benign Strictures in Patients with Inflammatory Bowel Disease
    Hye Won Lee, Soo Jung Park, Seong Ran Jeon, Byong Duk Ye, Jae Jun Park, Jae Hee Cheon, Tae Il Kim, Won Ho Kim
    Gut and Liver.2018; 12(5): 530.     CrossRef
  • Association of Perianal Fistulas with Clinical Features and Prognosis of Crohn's Disease in Korea: Results from the CONNECT Study
    Jaeyoung Chun, Jong Pil Im, Ji Won Kim, Kook Lae Lee, Chang Hwan Choi, Hyunsoo Kim, Jae Hee Cheon, Byong Duk Ye, Young-Ho Kim, You Sun Kim, Yoon Tae Jeen, Dong Soo Han, Won Ho Kim, Joo Sung Kim
    Gut and Liver.2018; 12(5): 544.     CrossRef
  • Computed tomography and magnetic resonance imaging in the diagnosis of the small and large intestine strictures in Crohn’s disease. Radiological semiotics and assessment of the inflammation activity
    S. E. Dubrova, G. A. Stashuk, N. V. Nikitina, Yu. K. Bogomazov
    Almanac of Clinical Medicine.2018; 46(7): 725.     CrossRef
  • A distinct epigenetic profile distinguishes stenotic from non-inflamed fibroblasts in the ileal mucosa of Crohn’s disease patients
    Andrew Y. F. Li Yim, Jessica R. de Bruyn, Nicolette W. Duijvis, Catriona Sharp, Enrico Ferrero, Wouter J. de Jonge, Manon E. Wildenberg, Marcel M. A. M. Mannens, Christianne J. Buskens, Geert R. D’Haens, Peter Henneman, Anje A. te Velde, Osman El-Maarri
    PLOS ONE.2018; 13(12): e0209656.     CrossRef
  • Management of Crohn's disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease
    Shu-Chen Wei, Ting-An Chang, Te-Hsin Chao, Jinn-Shiun Chen, Jen-Wei Chou, Yenn-Hwei Chou, Chiao-Hsiung Chuang, Wen-Hung Hsu, Tien-Yu Huang, Tzu-Chi Hsu, Chun-Chi Lin, Hung-Hsin Lin, Jen-Kou Lin, Wei-Chen Lin, Yen-Hsuan Ni, Ming-Jium Shieh, I-Lun Shih, Chi
    Intestinal Research.2017; 15(3): 285.     CrossRef
  • Biodegradable Stents
    Deepanshu Jain, Ejaz Mahmood, Shashideep Singhal
    Journal of Clinical Gastroenterology.2017; 51(4): 295.     CrossRef
  • Quality Indicators for Small Bowel Capsule Endoscopy
    Ki-Nam Shim, Seong Ran Jeon, Hyun Joo Jang, Jinsu Kim, Yun Jeong Lim, Kyeong Ok Kim, Hyun Joo Song, Hyun Seok Lee, Jae Jun Park, Ji Hyun Kim, Jaeyoung Chun, Soo Jung Park, Dong-Hoon Yang, Yang Won Min, Bora Keum, Bo-In Lee
    Clinical Endoscopy.2017; 50(2): 148.     CrossRef
  • Editorial: Factors Promoting Development of Fibrosis in Crohn’s Disease
    Jennifer Bailey
    Frontiers in Medicine.2017;[Epub]     CrossRef
  • Circulating cathelicidin levels correlate with mucosal disease activity in ulcerative colitis, risk of intestinal stricture in Crohn’s disease, and clinical prognosis in inflammatory bowel disease
    Diana Hoang-Ngoc Tran, Jiani Wang, Christina Ha, Wendy Ho, S. Anjani Mattai, Angelos Oikonomopoulos, Guy Weiss, Precious Lacey, Michelle Cheng, Christine Shieh, Caroline C. Mussatto, Samantha Ho, Daniel Hommes, Hon Wai Koon
    BMC Gastroenterology.2017;[Epub]     CrossRef
  • Advanced Oxidation Protein Products Induce Epithelial–Mesenchymal Transition of Intestinal Epithelial Cellsviaa PKC δ-Mediated, Redox-Dependent Signaling Pathway
    Xiaoping Xu, Shibo Sun, Fang Xie, Juanjuan Ma, Jing Tang, Shuying He, Lan Bai
    Antioxidants & Redox Signaling.2017; 27(1): 37.     CrossRef
  • Incidence of and Risk Factors for Free Bowel Perforation in Patients with Crohn’s Disease
    Jong Wook Kim, Ho-Su Lee, Byong Duk Ye, Suk-Kyun Yang, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Kyung-Jo Kim, Jeong-Sik Byeon, Seung-Jae Myung, Yong Sik Yoon, Chang Sik Yu, Jin-Ho Kim
    Digestive Diseases and Sciences.2017; 62(6): 1607.     CrossRef
  • Crohn’s disease presenting as gastric outlet obstruction: a therapeutic challenge?
    Faisal Inayat, Waqas Ullah, Qulsoom Hussain, Khurram Shafique
    BMJ Case Reports.2017; 2017: bcr-2016-218181.     CrossRef
  • Genetic Influences on the Development of Fibrosis in Crohn’s Disease
    Bram Verstockt, Isabelle Cleynen
    Frontiers in Medicine.2016;[Epub]     CrossRef
  • Crohn's Disease: Specific Concerns in the Elderly
    Wei-Chen Lin, Ming-Jen Chen, Cheng-Hsin Chu, Tsang-En Wang, Horng-Yuan Wang, Shou-Chuan Shih, Chen-Wang Chang
    International Journal of Gerontology.2016; 10(3): 126.     CrossRef
  • Structural and molecular features of intestinal strictures in rats with Crohn's-like disease
    Petra Talapka
    World Journal of Gastroenterology.2016; 22(22): 5154.     CrossRef
  • Disease Phenotype, Activity and Clinical Course Prediction Based on C-Reactive Protein Levels at Diagnosis in Patients with Crohn’s Disease: Results from the CONNECT Study
    Jee Hye Kwon, Jong Pil Im, Byong Duk Ye, Jae Hee Cheon, Hyun Joo Jang, Kang Moon Lee, You Sun Kim, Sang Wook Kim, Young Ho Kim, Geun Am Song, Dong Soo Han, Won Ho Kim, Joo Sung Kim
    Gut and Liver.2016; 10(4): 595.     CrossRef
  • Small Bowel Stricture Mimicking Megacolon in a Patient with Crohn's Disease
    Samuel Raimundo Fernandes, Luís Araújo Correia, José Velosa
    GE Portuguese Journal of Gastroenterology.2016; 23(6): 319.     CrossRef
  • Factors Associated with Anxiety and Depression in Korean Patients with Inactive Inflammatory Bowel Disease
    Min Chul Kim, Yoon Suk Jung, Young Seok Song, Jung In Lee, Jung Ho Park, Chong Il Sohn, Kyu Yong Choi, Dong Il Park
    Gut and Liver.2016;[Epub]     CrossRef
  • Disease monitoring in inflammatory bowel disease
    Shannon Chang
    World Journal of Gastroenterology.2015; 21(40): 11246.     CrossRef
  • Endoskopie in Diagnose, Therapie und Nachsorge
    H. Neumann, M. F. Neurath, Raja Atreya
    MMW - Fortschritte der Medizin.2015; 157(12): 63.     CrossRef
  • Endoscopic Therapy in Inflammatory Bowel Diseases
    Helmut Neumann, Markus F. Neurath, Raja Atreya
    Visceral Medicine.2015; 31(4): 280.     CrossRef
  • 14,555 View
  • 89 Download
  • 66 Web of Science
  • 71 Crossref
Close layer

Intest Res : Intestinal Research
Close layer
TOP